Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery

Autor: Philippe Koehrer, Alain M. Bron, Catherine Creuzot-Garcher, André Juniot, M. Passemard
Přispěvatelé: Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Centre des Sciences du Goût et de l'Alimentation [Dijon] ( CSGA ), Institut National de la Recherche Agronomique ( INRA ) -Université de Bourgogne ( UB ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique ( CNRS ), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre des Sciences du Goût et de l'Alimentation [Dijon] (CSGA), Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique (CNRS)
Rok vydání: 2012
Předmět:
Male
Eye Hemorrhage
genetic structures
Conscious Sedation
Electrocardiography
Oximetry
Young adult
Aged
80 and over

Aspirin
medicine.diagnostic_test
Incidence (epidemiology)
Anticoagulant
General Medicine
Middle Aged
Clopidogrel
Anesthesia
[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organs
Female
Orbit
medicine.drug
Adult
medicine.medical_specialty
Ticlopidine
medicine.drug_class
Postoperative Hemorrhage
Vitreoretinal Surgery
Young Adult
[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology
medicine
Humans
[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs
Aged
Retrospective Studies
business.industry
Acenocoumarol
Anticoagulants
Retrospective cohort study
Phenindione
eye diseases
Surgery
Ophthalmology
Warfarin
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Platelet Aggregation Inhibitors
Case series
Anesthesia
Local
Zdroj: RETINA
RETINA, Lippincott, Williams & Wilkins, 2012, 32 (9), pp.1868-1873
ISSN: 1539-2864
0275-004X
Popis: PURPOSE: : To establish the prevalence of anticoagulation (vitamin K antagonists) and antiplatelet agent therapy in patients undergoing vitreoretinal surgery and to compare the outcome of peribulbar anesthesia and vitreoretinal surgery between users and nonusers. METHODS: : We conducted a retrospective case series study in one academic center. No changes in the treatment regimen were made before surgery. Patients were divided into 3 groups: G1, patients with no anticoagulant or antiplatelet therapy; G2, patients treated with anticoagulants; and G3, patients treated with aspirin, clopidogrel, or both. RESULTS: : Two hundred and six eyes (206 patients) were included. G1, 144 eyes (69.9%) without any anticoagulant or antiplatelet therapy (69.9%); G2, 12 eyes (5.8%) with anticoagulants; and G3, 44 eyes (21.4%) with antiplatelet agents. Six patients (6 eyes) (2.9%) received both anticoagulant and antiplatelet agents. The incidence of overall and mild postoperative hemorrhagic complications was similar between groups, P = 0.075 and P = 0.127, respectively. However, potential sight-threatening hemorrhagic complications were more frequent in patients receiving antiplatelet agents, P < 0.003. CONCLUSION: : Peribulbar anesthesia for vitreoretinal surgery can probably be performed safely in patients receiving anticoagulants. However, retinal surgeons should be aware that severe bleeding complications are more frequent in patients receiving antiplatelet therapy.
Databáze: OpenAIRE